SNY - Sanofi's $20B Consumer Health Unit Sale: Goldman Sachs Morgan Stanley Line Up $6.5B Financing | Benzinga
Goldman Sachs Group Inc. (NYSE:GS) and Morgan Stanley (NYSE:MS) are reportedly preparing to arrange more than $6.5 billion (6 billion euros) in debt financing for potential buyers interested in acquiring Sanofi SA’s (NASDAQ:SNY) consumer health division.
This move highlights banks’ strong interest in supporting leveraged buyouts through pre-arranged financing.
The financing effort, spearheaded by Goldman Sachs and Morgan Stanley, forms part of Sanofi’s strategy to divest its $20 billion consumer health business.
Advisers, including Bank of America Corp. (NYSE:BAC) and BNP Paribas SA are also involved in the financing, Bloomberg noted citing the sources familiar with the matter.